First-In-Human (FIH) to Proof-Of-Concept (PoC) Studies in Japan for Early Access of Pharmaceuticals for Patients Around the World, Even at an International Pharmaceutical Company

Proceedings for Annual Meeting of The Japanese Pharmacological Society
doi 10.1254/jpssuppl.93.0_1-js1-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Pharmacological Society

Related search

Early Market Access for Pharmaceuticals in EU: What Is the Impact of Ema’s Accelerated Assessment Procedure?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Banking Services for Everyone? Barriers to Bank Access and Use Around the World

World Bank Economic Review
DevelopmentAccountingEconomicsEconometricsFinance
2008English

A Postmodernization of Customary International Law for the First World?

AJIL Unbound
Law
2018English

Establishing an Open Access Rating Web-System for Assessing the Development of Cities and Countries Around the World

Research Result. INFORMATION TECHNOLOGIES
2016English

Evaluation of an Intervention for the Prevention of Musculoskeletal Disorders in Workers of a Pharmaceutical Company

Archivos de Prevención de Riesgos Laborales
2015English

Behavior-Based Network Access Control: A Proof-Of-Concept

Lecture Notes in Computer Science
Computer ScienceTheoretical Computer Science
English

Terahertz Imaging for Early Screening of Diabetic Foot Syndrome: A Proof of Concept

Scientific Reports
Multidisciplinary
2017English

Closed-Loop Control for Precision Antimicrobial Delivery: An in Silico Proof-Of-Concept

IEEE Transactions on Biomedical Engineering
Biomedical Engineering
2018English

E-Learning in Medical Education in Japan and Around the World

Journal of Nihon University Medical Association
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy